Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,854,624
+$43,162 QoQ
Shares Held
11,834
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#449
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. NVS ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,854,624 | 11,834 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,811,462 | 11,859 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,714,275 | 12,434 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,568,888 | 12,234 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,482,735 | 12,253 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,300,860 | 11,669 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,135,510 | 11,669 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,365,172 | 11,869 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,174,999 | 11,037 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,067,415 | 11,035 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,168,222 | 11,570 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,183,816 | 11,622 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,205,571 | 11,947 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,101,700 | 11,975 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,131,732 | 12,475 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $951,721 | 12,521 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,025,348 | 12,130 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,043,786 | 11,895 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,042,292 | 11,916 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $909,066 | 11,116 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,014,223 | 11,116 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $928,654 | 10,864 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,054,216 | 11,164 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,032,128 | 11,869 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,038,385 | 11,889 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $980,248 | 11,889 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||